Description: Predictive Technology Group, Inc. (PRED), through its wholly owned subsidiaries, revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company develops and/or acquires proprietary technologies that open windows into the origin of human disease and the role that genes and their related proteins play in diseases onsets and progressions. PRED's subsidiaries use gene-based information as cornerstones in the development of new diagnostics that assess a person's risk of disease and therapeutic products designed to effectively prevent and/or treat diseases, www.predictivetechnologygroup.com
Home Page: www.predtechgroup.com
2735 Parleys Way
Salt Lake City,
UT
84109
United States
Phone:
801 584 3600
Officers
| Name | Title |
|---|---|
| Mr. Bradley C. Robinson | CEO, Pres & Director |
| Dr. Michael Dey Ph.D. | CEO of Predictive Therapeutics & Director |
| Mr. Simon Brewer CPA | Consultant |
| Dr. Bruce D. Forrest B.S., M.B.A., M.D. | Chief Devel. Officer |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.0028 |
| Price-to-Sales TTM: | 0.0047 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 62 |